Search for: "Apotex" Results 601 - 620 of 1,046
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Dec 2010, 9:55 pm by Patent Docs
The case involved two challenges filed by the appellants, Apotex... [read post]
15 Dec 2010, 2:17 am by Kelly
Becton, Dickinson & Co (Intellectual Property Law Blog) US: Regents of the University of California pursue new patent re-examination in District Court (Patents Post Grant Blog) US: Microsoft v i4i, the burden of proof and the pharma sector (PatLit) US: IRS issues notice to implement annual fee on brand drugs (FDA Law Blog) US: Bright ‘orphan’ ideas blossom (FDA Law Blog) US: Amicus briefs in AMP v USPTO (Patent Docs) (Patent Docs) (Patent Docs) US: University of California files for… [read post]
8 Dec 2010, 2:20 am by Marie Louise
: Daiichi Sankyo Co Ltd v Comptroller General of Patents (The SPC Blog) Coversyl (Perindopril) – Australia: FCAFC: Servier denied patent amendment on appeal: Les Laboratoires Servier v Apotex (Patentology) Prandin (Repaglinide) – US: Paddock fails to dismiss Novo’s Prandin patent suit (Patent Docs) Spiriva (Tiotropium bromide monohydrate) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Temodar (Temozolomide) – US:… [read post]
1 Dec 2010, 12:15 am by Kelly
TM 216996 – Schering Plough (The IP Factor) Concerta (Methylphenidate) – US: Impax Laboratories confirms patent suit relating to generic Concerta 54 mg tablets (SmartBrief) Hycamtin (Topotecan) – US: APP Pharmaceuticals announces approval and launch of Topotecan for injection (SmartBrief) Lovaza (Omega-3) – US: Pronova Biopharma receives Lovaza paragraph IV notice letter from Apotex Inc (GenericsWeb) Naropin (Ropivacaine) – UK: Assigned or not? [read post]
18 Nov 2010, 9:11 pm by Patent Docs
In 2007, Otsuka sued several defendants, including Teva, Apotex, and Sandoz, after the defendants filed Abbreviated New Drug Applications (ANDAs) for aripiprazole, which Otsuka claimed infringed U.S. [read post]
17 Nov 2010, 1:48 am by Kelly
McNeil (EPLAW) Zymar (Gatifloxacin) – US: Allergan fails to secure new trial in Zymar case: Senju et al v Apotex (Patent Docs) [read post]
11 Nov 2010, 9:59 pm by Patent Docs
In September 2007, Roche sued Apotex and Cobalt in the U.S. [read post]
10 Nov 2010, 1:11 am by Kelly
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva in… [read post]
5 Nov 2010, 1:38 pm
Apotex Corp., 439 F.3d 1312, 1319 (Fed. [read post]
4 Nov 2010, 9:59 pm by Patent Docs
Apotex asserted that U.S. [read post]
4 Nov 2010, 6:14 am by Lawrence B. Ebert
She explained that the FDA responded by instructing Apotex to delete this phrase and sending Apotex a template containing the language Apotex was to include in the proposed label. [read post]
3 Nov 2010, 1:21 am by Kelly
General Bell tolls for biodiversity benefit-sharing treaty (IP Watch) Ministers arrive to help reach outcome at UN convention on biodiversity (IP Watch) Delegates see UN protocol against biopiracy within reach (IP Watch) Pfizer and Biocon sign global commercialisation agreement on biosimilars (Patent Docs) Brazil: Paragraph 6 system: Brazilian intervention at the WTO TRIPS Council (KEI) Canada’s intervention to TRIPS Council: Experience using the System (Apotex-Rwanda Case) (KEI)… [read post]
2 Nov 2010, 1:40 am
At the hearing, Apotex argued that U.S. [read post]